These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


91 related items for PubMed ID: 7229511

  • 1. Interactions of glucose-6-phosphate dehydrogenase deficiency with drug acetylation and hydroxylation reactions.
    Magon AM, Leipzig RM, Zannoni VG, Brewer GJ.
    J Lab Clin Med; 1981 Jun; 97(6):764-70. PubMed ID: 7229511
    [Abstract] [Full Text] [Related]

  • 2. Pharmacogenetic interactions in G6PD deficiency and development of an in vitro test to predict a drug's hemolytic potential.
    Magon A, Leipzig RM, Bloom K, Brewer GJ.
    Prog Clin Biol Res; 1981 Jun; 55():709-24. PubMed ID: 7291202
    [Abstract] [Full Text] [Related]

  • 3. Dapsone-induced hemolytic anemia: role of glucose-6-phosphate dehydrogenase in the hemolytic response of rat erythrocytes to N-hydroxydapsone.
    Grossman S, Budinsky R, Jollow D.
    J Pharmacol Exp Ther; 1995 May; 273(2):870-7. PubMed ID: 7752092
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The potential use of xylitol in glucose-6-phosphate dehydrogenase deficiency anemia.
    Wang YM, Patterson JH, Van Eys J.
    J Clin Invest; 1971 Jul; 50(7):1421-8. PubMed ID: 4397414
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Attempts to predict the hemolytic potential of drugs in glucose-6-phosphate dehydrogenase deficiency of the Mediterranean type by an in vitro test.
    Bashan N, Peleg N, Moses SW.
    Isr J Med Sci; 1988 Jan; 24(1):61-4. PubMed ID: 3346155
    [No Abstract] [Full Text] [Related]

  • 11. Pro-oxidative effects of Chinese herbal medicine on G6PD-deficient erythrocytes in vitro.
    Ko CH, Li K, Ng PC, Fung KP, Wong RP, Chui KM, Gu GJ, Yung E, Fok TF.
    Toxicol In Vitro; 2008 Aug; 22(5):1222-7. PubMed ID: 18515042
    [Abstract] [Full Text] [Related]

  • 12. Inability to maintain GSH pool in G6PD-deficient red cells causes futile AMPK activation and irreversible metabolic disturbance.
    Tang HY, Ho HY, Wu PR, Chen SH, Kuypers FA, Cheng ML, Chiu DT.
    Antioxid Redox Signal; 2015 Mar 20; 22(9):744-59. PubMed ID: 25556665
    [Abstract] [Full Text] [Related]

  • 13. Acetylator phenotype among individuals with glucose 6-phosphate dehydrogenase variants.
    Jeyakumar LH, French MR.
    Xenobiotica; 1986 Dec 20; 16(12):1129-32. PubMed ID: 3798960
    [Abstract] [Full Text] [Related]

  • 14. Augmented IL-10 production and redox-dependent signaling pathways in glucose-6-phosphate dehydrogenase-deficient mouse peritoneal macrophages.
    Wilmanski J, Siddiqi M, Deitch EA, Spolarics Z.
    J Leukoc Biol; 2005 Jul 20; 78(1):85-94. PubMed ID: 15817708
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Haemolytic potential of three chemotherapeutic agents and aspirin in glucose-6-phosphate dehydrogenase deficiency.
    Ali NA, al-Naama LM, Khalid LO.
    East Mediterr Health J; 1999 May 20; 5(3):457-64. PubMed ID: 10793824
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.